Voya Investment Management LLC Sells 234,370 Shares of Intuitive Surgical, Inc. $ISRG

Voya Investment Management LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 652,769 shares of the medical equipment provider’s stock after selling 234,370 shares during the period. Voya Investment Management LLC owned approximately 0.18% of Intuitive Surgical worth $291,697,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Tobam raised its stake in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the last quarter. Kilter Group LLC purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth $27,000. TD Capital Management LLC grew its holdings in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. 1248 Management LLC purchased a new stake in Intuitive Surgical during the first quarter valued at $30,000. Finally, Princeton Global Asset Management LLC bought a new position in Intuitive Surgical in the second quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, Director Craig H. Barratt sold 750 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $435,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 464 shares of the stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the sale, the senior vice president owned 131 shares of the company’s stock, valued at $71,852.19. This represents a 77.98% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 114,007 shares of company stock worth $63,533,844 in the last three months. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $561.89 on Friday. The company has a market capitalization of $201.42 billion, a P/E ratio of 74.32, a P/E/G ratio of 5.12 and a beta of 1.68. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The firm’s 50 day simple moving average is $538.62 and its two-hundred day simple moving average is $506.16.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period in the prior year, the company posted $1.84 earnings per share. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research reports. BTIG Research raised their target price on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. HSBC raised their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Piper Sandler boosted their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Leerink Partners increased their price target on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $611.08.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.